- Home
- POAI vs EKSO Comparison
POAI vs EKSO Comparison
Compare POAI & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- EKSO
- Stock Information
- Founded
- POAI 2002
- EKSO 2005
- Country
- POAI United States
- EKSO United States
- Employees
- POAI N/A
- EKSO N/A
- Industry
- POAI Industrial Specialties
- EKSO Medical/Dental Instruments
- Sector
- POAI Health Care
- EKSO Health Care
- Exchange
- POAI Nasdaq
- EKSO Nasdaq
- Market Cap
- POAI 6.5M
- EKSO 7.7M
- IPO Year
- POAI N/A
- EKSO N/A
- Fundamental
- Price
- POAI $6.18
- EKSO $4.65
- Analyst Decision
- POAI Hold
- EKSO Strong Buy
- Analyst Count
- POAI 1
- EKSO 2
- Target Price
- POAI N/A
- EKSO $34.75
- AVG Volume (30 Days)
- POAI 44.5K
- EKSO 44.9K
- Earning Date
- POAI 11-14-2025
- EKSO 10-28-2025
- Dividend Yield
- POAI N/A
- EKSO N/A
- EPS Growth
- POAI N/A
- EKSO N/A
- EPS
- POAI N/A
- EKSO N/A
- Revenue
- POAI $1,664,696.00
- EKSO $14,749,000.00
- Revenue This Year
- POAI $486.27
- EKSO N/A
- Revenue Next Year
- POAI $65.50
- EKSO $49.96
- P/E Ratio
- POAI N/A
- EKSO N/A
- Revenue Growth
- POAI 71.65
- EKSO N/A
- 52 Week Low
- POAI $4.76
- EKSO $2.73
- 52 Week High
- POAI $45.90
- EKSO $14.97
- Technical
- Relative Strength Index (RSI)
- POAI 36.97
- EKSO 44.72
- Support Level
- POAI $8.05
- EKSO $5.00
- Resistance Level
- POAI $9.47
- EKSO $5.27
- Average True Range (ATR)
- POAI 0.94
- EKSO 0.42
- MACD
- POAI -0.64
- EKSO -0.05
- Stochastic Oscillator
- POAI 26.61
- EKSO 18.57
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.